Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diet composition for the prevention and/or the treatment of endometrial hyperplasia

A technology of endometrial hyperplasia and diet, which is applied in the direction of food ingredients, functions of food ingredients, endocrine system diseases, etc., can solve problems such as inability to make fasting or FMD curative effect

Inactive Publication Date: 2019-11-01
UNIV DEGLI STUDI DI GENOVA GENOVA IT +1
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] However, no reliable predictions can be made of the likely benefit of fasting or FMD for the prevention and / or treatment of endometrial hyperplasia, especially after the use of tamoxifen or other selective estrogen receptor modulators

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diet composition for the prevention and/or the treatment of endometrial hyperplasia
  • Diet composition for the prevention and/or the treatment of endometrial hyperplasia
  • Diet composition for the prevention and/or the treatment of endometrial hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0060] The present invention relates to a dietary composition as described above for the prevention and / or treatment of endometrial hyperplasia. The dietary composition is as described above for women at risk of developing endometrial hyperplasia or with a previous diagnosis of endometrial hyperplasia (after HRT or ingestion of tamoxifen, in the Indications for use of this dietary ingredient exist, especially when menstrual irregularities reflect polycystic ovary syndrome). In particular, the use of this dietary component does not preclude hysterectomy in the presence of atypical hyperplasia requiring hysterectomy.

[0061] found that animals treated for four weeks with tamoxifen, a drug that induces endometrial hyperplasia as a partial ER stimulant at the uterine level, had increased uterine weight ( figure 1 A and figure 1 B is visible), the size of the uterus itself increases ( figure 2 ) and the histological pattern of endometrial hyperplasia ( image 3 ), which sup...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Diet composition for use in the prevention and / or the treatment of endometrial hyperplasia in a human subject comprising a) a fasting mimicking diet component to be administered for a first period oftime and providing less than 50% of the normal caloric intake of the subject with both protein restriction and sugar restriction; and b) a re-feeding diet component to be administered for a second time period, which provides 60-100% of the normal caloric intake of the subject, wherein the fasting mimicking diet component and the re-feeding diet component are administered over multiple cycles.

Description

technical field [0001] The technical field of the invention relates to the technical fields of the pharmaceutical and food industries. [0002] In particular, the present invention relates to dietary ingredients for the prevention and / or treatment of endometrial hyperplasia in human subjects. Background technique [0003] Endometrial hyperplasia is a condition characterized by thickening of the uterine lining (endometrium) in response to estrogen levels disproportionate to progesterone levels (https: / / www.rcog.org.uk / globalassets / documents / guidelines / green-topguidelines / gtg_67_endometrial_hyperplasia.pdf). [0004] Conditions that predispose to endometrial hyperplasia include use of selective estrogen receptor modulators (ERs), such as tamoxifen (a drug used to treat breast cancer), postmenopausal estrogen intake [hormone replacement therapy (HRT)] , obesity, and menstrual irregularities, especially in women with polycystic ovary syndrome. Endometrial hyperplasia can cau...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/00A23L33/20
CPCA23L33/30A23L33/20A61P15/00A61P15/12A61P5/32A23V2002/00A23V2200/332A23L33/12A23L33/125A23L33/185
Inventor 阿莱西奥·内西奥尼艾琳·卡法帕梅拉·贝切里尼瓦尔特·隆戈
Owner UNIV DEGLI STUDI DI GENOVA GENOVA IT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com